Jin Medical International Co., Inc. (NASDAQ: ZJYL) is a U.S.-listed healthcare company specializing in elective medical services and aesthetic surgery. Through its network of affiliated hospitals and clinics, the company offers a range of cosmetic and reconstructive procedures, including plastic surgery, dermatology treatments, dental aesthetics, anti‐aging therapies and ophthalmic care. Its facilities serve both domestic and international patients, with primary operations located in key Chinese cities and strategic partnerships across Asia Pacific.
Founded in 2013 and headquartered in Miami, Jin Medical International has expanded its footprint by acquiring and integrating specialty hospitals and outpatient clinics. These include leading plastic surgery centers in Shijiazhuang and Kunming, which have been developed into comprehensive medical beauty hubs. The company leverages digital platforms for appointment management and telemedicine consultations, enhancing patient access to pre- and post-operative care. In addition to clinical services, Jin Medical International provides professional training programs for its medical staff, drawing on expertise from international advisory members.
Over the years, Jin Medical’s growth strategy has focused on combining Western medical protocols with traditional Chinese aesthetic philosophies. The leadership team is composed of healthcare industry veterans, including Dr. Qiang Li, Chief Executive Officer, and Ms. Yanfang Xu, Chief Financial Officer, supported by an international board of medical advisors. This governance structure underpins the company’s commitment to high standards of patient safety, quality outcomes and innovation in aesthetic medicine.
Looking ahead, Jin Medical International aims to strengthen its regional market share through continued investment in technology, expanded service offerings and selective partnerships. By integrating advanced imaging systems, AI-assisted diagnostics and minimally invasive techniques, the company seeks to enhance treatment precision and patient satisfaction while pursuing opportunities in emerging markets across Southeast Asia.
AI Generated. May Contain Errors.
